The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.
Article obtained from Photonics RSS Feed.
Olympus Corp. of the Americas, a leading manufacturer of research microscopes, and Cytosurge, a Swiss-based precision manufacturer of cell manipulation technologies, have formalized a partnership to become a complete system provider to the scientific community for single-cell and CRISPR genetic manipulation solutions. The agreement establishes the opportunity for Cytosurge to continue its collaboration with Olympus and to introduce its technology to North American markets.
“We are very excited to formalize a partnership with Cytosurge, as we have worked with them for many years,” said Lee Wagstaff, vice president of life science sales and marketing at Olympus Corp. of the Americas. “With [CytoSurge’s] FluidFM…READ MORE